Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Treasury Shares: 2011-2025

Historic Treasury Shares for Niagen Bioscience (NAGE) over the last 3 years, with Sep 2025 value amounting to $1.5 million.

  • Niagen Bioscience's Treasury Shares rose 122.08% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 122.08%. This contributed to the annual value of $609,000 for FY2024, which is 3.40% up from last year.
  • Per Niagen Bioscience's latest filing, its Treasury Shares stood at $1.5 million for Q3 2025, which was down 0.00% from $1.5 million recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Treasury Shares peaked at $1.5 million during Q1 2025, and registered a low of $589,000 during Q4 2023.
  • Its 3-year average for Treasury Shares is $956,800, with a median of $779,000 in 2023.
  • Its Treasury Shares has fluctuated over the past 5 years, first fell by 9.38% in 2023, then surged by 122.08% in 2025.
  • Quarterly analysis of 4 years shows Niagen Bioscience's Treasury Shares stood at $650,000 in 2022, then declined by 9.38% to $589,000 in 2023, then climbed by 3.40% to $609,000 in 2024, then surged by 122.08% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.5 million for Q2 2025, and $1.5 million during Q1 2025.